Publikationen

A Novel Chemical Entity that Reverses Warburg Metabolism by Disrupting VDAC1/HK2 Interaction through “Toposteric Effect” in Cancer

Hexokinase 2 Modulator for Field-Directed Treatment of Experimental Actinic Keratoses

MedNous, Mai 2024

Max Herzberg: Fallstudie zur Krebsforschung — Protein-Fehllokalisation bei Krebs

Eilat Symposium on Pediatric Cancer 2026

Fallstudie: Compassionate Use von subkutanem VDA-1102 (Almavid®) bei pädiatrischem Ependymom

SITC 2018

Modulating Hexokinase 2 (HK2) as a Novel Approach for Simultaneous Targeting of the Tumor and Its Immunosuppressive Microenvironment

Fall Clinical Dermatology Conference® 2018

Eine neuartige, gut verträgliche Behandlung der aktinischen Keratose

AACR 2018

Activating the NLRP3 Inflammasome in Macrophages and Triggering Apoptosis in Cancer Cells via HK2/VDAC Modulator